205 related articles for article (PubMed ID: 25867718)
21. Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea.
Yoon K; Kim N; Nam RH; Suh JH; Lee S; Kim JM; Lee JY; Kwon YH; Choi YJ; Yoon H; Shin CM; Park YS; Lee DH
J Gastroenterol Hepatol; 2015 Mar; 30(3):490-5. PubMed ID: 25363555
[TBL] [Abstract][Full Text] [Related]
22. Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
Abuhammour A; Dajani A; Nounou M; Zakaria M
Arab J Gastroenterol; 2016 Sep; 17(3):131-136. PubMed ID: 27665525
[TBL] [Abstract][Full Text] [Related]
23. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
Huang YK; Wu MC; Wang SS; Kuo CH; Lee YC; Chang LL; Wang TH; Chen YH; Wang WM; Wu DC; Kuo FC
J Dig Dis; 2012 Apr; 13(4):232-8. PubMed ID: 22435509
[TBL] [Abstract][Full Text] [Related]
24. Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Tepeš B; Vujasinović M; Šeruga M; Stefanovič M; Forte A; Jeverica S
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):676-83. PubMed ID: 26862930
[TBL] [Abstract][Full Text] [Related]
25. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
[TBL] [Abstract][Full Text] [Related]
26. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781
[TBL] [Abstract][Full Text] [Related]
28. Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study.
Chung JW; Han JP; Kim KO; Kim SY; Hong SJ; Kim TH; Kim CW; Kim JS; Kim BW; Bang BW; Kim HG; Yun SC;
Dig Liver Dis; 2016 Aug; 48(8):888-92. PubMed ID: 27257049
[TBL] [Abstract][Full Text] [Related]
29. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
[TBL] [Abstract][Full Text] [Related]
31. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Kwon JH; Lee DH; Song BJ; Lee JW; Kim JJ; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC; Song IS
Helicobacter; 2010 Apr; 15(2):148-53. PubMed ID: 20402817
[TBL] [Abstract][Full Text] [Related]
32. Delay of second-line eradication therapy for Helicobacter pylori can increase eradication failure.
Nishizawa T; Suzuki H; Takahashi M; Suzuki M; Hibi T
J Gastroenterol Hepatol; 2013 Oct; 28(10):1608-10. PubMed ID: 23701705
[TBL] [Abstract][Full Text] [Related]
33. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
34. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
[TBL] [Abstract][Full Text] [Related]
37. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
38. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
39. Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Hsu PI; Tsay FW; Kao JY; Peng NJ; Tsai KW; Tsai TJ; Kuo CH; Kao SS; Wang HM; Chen YH; Shie CB; Wu DC;
J Gastroenterol Hepatol; 2020 Oct; 35(10):1731-1737. PubMed ID: 32167605
[TBL] [Abstract][Full Text] [Related]
40. Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.
Bontems P; Kalach N; Oderda G; Salame A; Muyshont L; Miendje DY; Raymond J; Cadranel S; Scaillon M
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):646-50. PubMed ID: 21701406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
